Clinical trial
Rituximab for the Treatment of New-onset AChR-Myasthenia Gravis
NCT07071246 is registered in ClinicalTrials.gov with Tang-Du Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Rituximab for the Treatment of New-onset AChR-Myasthenia Gravis
- Lead sponsor
- Tang-Du Hospital
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- August 1, 2022
- Completion date
- July 31, 2027
- Enrollment
- 30 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
treatment